SynthesisCancer medicine2018

The benefit and risk of nivolumab in non-small-cell lung cancer: a single-arm meta-analysis of noncomparative clinical studies and randomized controlled trials.

Binghao Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.